Trials / Conditions / Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

196 registered clinical trials studyying Seasonal Allergic Rhinitis — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis NCT07398859	Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.	Phase 2
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis NCT07436234	Akeso	Phase 2
Not Yet Recruiting	A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Se NCT07146126	Prime Gene Therapeutics Co., Ltd.	Phase 3
Recruiting	Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NCT07055542	University of Melbourne	N/A
Recruiting	A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patie NCT07091357	Guangdong Hengrui Pharmaceutical Co., Ltd	Phase 2
Completed	Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis NCT07052097	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Phase 2
Recruiting	Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasona NCT06846385	Shanghai Mabgeek Biotech.Co.Ltd	Phase 2 / Phase 3
Active Not Recruiting	A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal All NCT06837233	Prime Gene Therapeutics Co., Ltd.	Phase 2
Completed	Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis NCT06760182	Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.	Phase 2
Completed	Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults NCT06861101	Shanghai JunTop Biosciences Co., LTD	Phase 2
Active Not Recruiting	Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis NCT07291284	Longbio Pharma	Phase 3
Unknown	Study of CM310 in Subjects With Seasonal Allergic Rhinitis NCT06171074	Keymed Biosciences Co.Ltd	Phase 2
Recruiting	Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis NCT06300203	Beijing Tongren Hospital	Phase 2
Completed	Azelastine Allergen Chamber - Onset of Action Study NCT06126952	MEDA Pharma GmbH & Co. KG	Phase 2
Unknown	A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monomet NCT06200766	Zheng Liu ENT	Phase 3
Completed	Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult NCT06046391	Longbio Pharma	Phase 2
Terminated	Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mome NCT05887843	Sandoz	Phase 1
Completed	Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spra NCT06180083	Humanis Saglık Anonim Sirketi	Phase 1
Completed	Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Mom NCT05590598	Sandoz	Phase 3
Completed	A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis NCT05692154	Opella Healthcare Group SAS, a Sanofi Company	Phase 3
Completed	Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced NCT05540717	Allergy Therapeutics	Phase 3
Completed	Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis NCT05346718	Fraunhofer-Institute of Toxicology and Experimental Medicine	N/A
Completed	Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Pa NCT05311475	Sandoz	Phase 3
Completed	Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis NCT05098522	Revolo Biotherapeutics	Phase 2
Recruiting	Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis NCT04815668	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	N/A
Completed	To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone NCT04817800	Humanis Saglık Anonim Sirketi	Phase 1 / Phase 2
Completed	Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics NCT04670627	University of North Carolina, Chapel Hill	—
Completed	Dymista Allergen Chamber - Onset of Action Study NCT04652245	MEDA Pharma GmbH & Co. KG	Phase 4
Completed	The Efficacy of Preseasonal Omalizumab Treatment NCT04489121	Beijing Tongren Hospital	N/A
Unknown	The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy NCT04544774	Universitaire Ziekenhuizen KU Leuven	—
Unknown	Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Seasonal Allergic Rhinit NCT04052945	Beijing Tongren Hospital	N/A
Unknown	Effectiveness of Sodium Hyaluronate In Relieving Nasal Symptoms Of Children With Seasonal Allergic Rhinitis NCT04752956	Saglik Bilimleri Universitesi	N/A
Completed	A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients NCT03570957	Tanabe Pharma Corporation	Phase 1
Completed	Evaluation of Nasal Inflammatory Biomarkers NCT03450031	Fraunhofer-Institute of Toxicology and Experimental Medicine	N/A
Completed	Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients NCT03369704	Novartis Pharmaceuticals	Phase 3
Completed	Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis NCT03649139	Beijing Tongren Hospital	Phase 3
Completed	A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL NCT03931993	Allergy Therapeutics	Phase 1
Completed	MP-AzeFlu Allergen Chamber - Onset of Action Study NCT03004131	MEDA Pharma GmbH & Co. KG	Phase 4
Unknown	Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis NCT02807064	University of Campania Luigi Vanvitelli	Phase 3
Completed	Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosi NCT03097432	University Hospital of Cologne	—
Completed	Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic R NCT02631551	Glenmark Specialty S.A.	Phase 3
Completed	Psychological Factors That Influence Severity of Allergic Rhinitis NCT04709614	The University Clinic of Pulmonary and Allergic Diseases Golnik	—
Completed	Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ NCT02582073	Allergy Therapeutics	Phase 2
Unknown	4"S" - Seasonal Symptoms Suppression Study NCT02557269	Association Asthma, Bulgaria	Phase 4
Completed	Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Aller NCT02377895	3E Therapeutics Corporation	Phase 1 / Phase 2
Completed	Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis NCT02320396	Organon and Co	Phase 3
Completed	To Study GSP 301 in Patients With Seasonal Allergic Rhinitis NCT02318303	Glenmark Pharmaceuticals Ltd. India	Phase 2
Completed	Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis NCT01940146	Sun Pharma Advanced Research Company Limited	Phase 2
Completed	Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Su NCT02245360	Abbott	Phase 3
Unknown	Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista NCT02249663	Teva Pharmaceuticals USA	Phase 3
Completed	Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic R NCT02230696	Padagis LLC	Phase 3
Completed	Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia NCT02155881	AstraZeneca	Phase 3
Completed	Compliance and Usability Study Evaluating RHINIX™ Nasal Filters NCT02108379	University of Aarhus	N/A
Completed	Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma NCT02161107	Circassia Limited	Phase 2
Completed	Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever NCT02108574	University of Aarhus	N/A
Terminated	Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhi NCT02246920	Teva Pharmaceuticals USA	Phase 3
Completed	Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal NCT03444506	Glenmark Pharmaceuticals Ltd. India	Phase 2
Completed	Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma NCT02061670	Circassia Limited	Phase 2
Completed	Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spra NCT02125253	Amneal Pharmaceuticals, LLC	Phase 3
Completed	Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure C NCT02061709	Circassia Limited	Phase 2
Unknown	A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apote NCT02279563	Apotex Inc.	Phase 2
Completed	Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge NCT01983865	Fraunhofer-Institute of Toxicology and Experimental Medicine	N/A
Terminated	Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis NCT01921348	University of Mississippi Medical Center	N/A
Completed	Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR NCT01915823	Meda Pharmaceuticals	Phase 3
Completed	Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis NCT01857063	Organon and Co	Phase 3
Completed	Post Marketing Surveillance for Contac Bien Z in Japan NCT02020902	GlaxoSmithKline	—
Completed	Clinical Equivalence Study of Mometasone Nasal Spray NCT01850823	Actavis Inc.	Phase 3
Completed	Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR) NCT01753739	Bausch & Lomb Incorporated	Phase 2
Completed	Allergic Rhinitis Changes the Sinus Microbiome NCT01852513	University of Chicago	Phase 4
Completed	Assessment of Fluticasone Propionate on Ocular Allergy Symptoms NCT01817790	GlaxoSmithKline	Phase 3
Completed	Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis NCT01748344	Ono Pharmaceutical Co., Ltd.	Phase 2
Completed	Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinit NCT02130440	University of Campania Luigi Vanvitelli	Phase 3
Completed	A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 5 NCT01673659	Padagis LLC	Phase 3
Completed	Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis NCT01651871	Shionogi	Phase 2
Completed	Effect of a Probiotic on Seasonal Allergic Rhinitis Symptoms NCT01653652	Société des Produits Nestlé (SPN)	N/A
Completed	Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation NCT01523236	Teva Pharmaceuticals USA	Phase 1 / Phase 2
Completed	Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis NCT01484119	Idorsia Pharmaceuticals Ltd.	Phase 3
Completed	Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Sp NCT01578278	Bausch & Lomb Incorporated	Phase 2
Completed	A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhiniti NCT01458275	Sumitomo Pharma America, Inc.	Phase 3
Completed	Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) NCT01549340	ALK-Abelló A/S	—
Completed	Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1) NCT01413958	Bayer	Phase 3
Completed	Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic R NCT01400828	Yuhan Corporation	Phase 3
Completed	Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals NCT01660698	Société des Produits Nestlé (SPN)	N/A
Completed	Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Al NCT01342601	Bitop AG	N/A
Completed	Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Aller NCT01307319	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Trial of STAHIST in Seasonal Allergic Rhinitis NCT01293201	Magna Pharmaceuticals, Inc.	Phase 3
Completed	A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray NCT02273817	Apotex Inc.	Phase 3
Completed	Rhinitis, Cognition and Driving Performance NCT01318681	Maastricht University Medical Center	N/A
Completed	Reduction of IgE Antibody in Human Allergic Subjects NCT01280149	Northwestern University	Phase 1
Completed	Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge NCT01260753	Palau Pharma S.L.U.	Phase 2
Completed	Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis NCT01277341	Bausch & Lomb Incorporated	Phase 2
Completed	Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis NCT01241214	Idorsia Pharmaceuticals Ltd.	Phase 2
Completed	Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis NCT01230619	Respivert Ltd	Phase 2
Completed	Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects NCT01171664	Magna Pharmaceuticals, Inc.	Phase 2
Terminated	Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on NCT01337323	GlaxoSmithKline	—
Completed	Vitamin D Plus Fluticasone Propionate NCT01103934	University of Chicago	Phase 4
Completed	Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in NCT01222299	Bausch & Lomb Incorporated	Phase 1 / Phase 2
Completed	Eosinophil Markers and Development of Disease in Allergic Rhinitis NCT01192386	University of Aarhus	—
Completed	Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis NCT00997620	Western Sky Medical Research	Phase 4
Completed	A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With S NCT01054352	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1
Completed	Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) NCT01024608	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the NCT01010971	Sumitomo Pharma America, Inc.	Phase 3
Completed	Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms NCT01007253	University of Chicago	Phase 4
Completed	A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific NCT01018693	Novartis Pharmaceuticals	Phase 2
Completed	AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis Patients NCT01271595	Charite University, Berlin, Germany	N/A
Completed	Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLET NCT00976209	Bayer	Phase 3
Completed	The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhin NCT00917020	Capnia, Inc.	Phase 2
Completed	The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis NCT00917111	Capnia, Inc.	Phase 2
Completed	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00883168	Meda Pharmaceuticals	Phase 3
Completed	Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal C NCT00845195	Alcon Research	Phase 4
Completed	Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR NCT00854360	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 2
Completed	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00824473	Meda Pharmaceuticals	Phase 3
Completed	Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the NCT00790023	Sumitomo Pharma America, Inc.	Phase 3
Completed	A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environ NCT00784732	Novartis	Phase 2
Completed	A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00740792	Meda Pharmaceuticals	Phase 3
Completed	The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis NCT00688441	Capnia, Inc.	Phase 2
Completed	Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen NCT00916422	Laboratorios Leti, S.L.	Phase 3
Completed	Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COM NCT00673062	Merck Sharp & Dohme LLC	Phase 2
Completed	A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Aller NCT00726401	Afexa Life Sciences Inc	Phase 2
Completed	Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic NCT00691665	Alcon Research	Phase 4
Completed	Acupuncture for Seasonal Allergic Rhinitis NCT00610584	Charite University, Berlin, Germany	N/A
Completed	Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis? NCT00618332	University of Chicago	N/A
Completed	A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With NCT00653224	UCB Pharma	Phase 4
Completed	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00651118	Meda Pharmaceuticals	Phase 3
Completed	A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With NCT00621959	UCB Pharma	Phase 4
Completed	Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Enviro NCT00940953	Ligand Pharmaceuticals	Phase 2
Completed	MOA Study of Ze 339 in Seasonal Allergic Rhinitis NCT00862225	Max Zeller Soehne AG	Phase 2
Completed	Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) NCT00564421	Merck Sharp & Dohme LLC	Phase 3
Completed	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00660517	Meda Pharmaceuticals	Phase 3
Completed	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00660829	Meda Pharmaceuticals	Phase 3
Completed	Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomati NCT00574379	Faes Farma, S.A.	Phase 2
Completed	A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induce NCT00561717	Bayer	Phase 4
Completed	PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the NCT00574210	Faes Farma, S.A.	Phase 2
Completed	Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract NCT00619827	Stallergenes Greer	Phase 1
Completed	Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients NCT00578929	Alcon Research	Phase 3
Completed	A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies NCT00720278	Meda Pharmaceuticals	Phase 3
Completed	A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies NCT00719862	Meda Pharmaceuticals	Phase 3
Completed	Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers NCT00483353	Pfizer	Phase 1
Completed	Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seaso NCT00552110	Organon and Co	Phase 2
Completed	Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms NCT00460538	Milsing d.o.o.	Phase 4
Completed	Intranasal Steroids and the Nasal Ocular Response NCT00473915	University of Chicago	Phase 4
Unknown	Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhin NCT00488176	Medical University of Lodz	Phase 4
Completed	Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Alle NCT00468312	Organon and Co	Phase 3
Completed	Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy NCT01475188	Ministry of Science and Higher Education, Poland	Phase 4
Completed	Montelukast as a Controller of Atopic Syndrome NCT00559546	University of Helsinki	Phase 4
Completed	A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage. NCT00517946	GlaxoSmithKline	—
Completed	Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of NCT00453063	Organon and Co	Phase 3
Completed	This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) T NCT00491504	Organon and Co	Phase 4
Completed	Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR NCT00938613	Ligand Pharmaceuticals	Phase 2
Completed	Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber NCT00430157	GlaxoSmithKline	Phase 2
Completed	Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen NCT00426179	Novartis	Phase 1 / Phase 2
Completed	A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis NCT00407927	Merck Sharp & Dohme LLC	Phase 2
Completed	Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study NCT00423995	Organon and Co	Phase 3
Completed	Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis NCT00443495	CMP Therapeutics Ltd	Phase 1 / Phase 2
Completed	A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challeng NCT00420082	Faes Farma, S.A.	Phase 2
Completed	Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections NCT00405899	West Penn Allegheny Health System	—
Completed	A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies NCT01368445	Meda Pharmaceuticals	Phase 3
Terminated	Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis NCT00361439	University of Chicago	Phase 4
Completed	Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symp NCT00334698	Fraunhofer-Institute of Toxicology and Experimental Medicine	N/A
Completed	Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED NCT00358527	Organon and Co	Phase 4
Withdrawn	Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo NCT00385463	Creighton University	N/A
Completed	A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions NCT00297843	Fraunhofer-Institute of Toxicology and Experimental Medicine	—
Completed	Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber NCT00377728	GlaxoSmithKline	Phase 2
Completed	Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhiniti NCT00305487	AstraZeneca	Phase 3
Completed	The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit NCT00209365	Fraunhofer-Institute of Toxicology and Experimental Medicine	N/A
Completed	Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis NCT00504933	Faes Farma, S.A.	Phase 3
Completed	POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) NCT00160537	UCB Pharma	Phase 4
Completed	Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P0425 NCT00816972	Organon and Co	Phase 2
Completed	Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis NCT00227058	University of Mississippi Medical Center	N/A
Completed	Study In Adults And Adolescents With Seasonal Allergic Rhinitis NCT00115622	GlaxoSmithKline	Phase 3
Terminated	Seasonal Allergic Rhinitis and Driving Ability NCT00223587	Utrecht Institute for Pharmaceutical Sciences	Phase 4
Completed	Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhini NCT00783211	Organon and Co	Phase 4
Completed	Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhini NCT00783146	Organon and Co	Phase 4
Completed	Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 NCT00637455	Sanofi	Phase 4
Completed	A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine NCT01108783	Faes Farma, S.A.	Phase 3
Completed	Rhinocort Aqua Versus Placebo and Fluticasone Propionate NCT00641680	AstraZeneca	Phase 3
Completed	Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Sin NCT00637611	Sanofi	Phase 4
Completed	Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy NCT01555736	Medical University of Lodz	Phase 4
Completed	Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) NCT00794846	Organon and Co	Phase 4
Completed	Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181) NCT00794495	Organon and Co	Phase 4
Completed	Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) NCT00794599	Organon and Co	Phase 4
Completed	Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177) NCT00783133	Organon and Co	Phase 4
Completed	Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178) NCT00794768	Organon and Co	Phase 4
Completed	Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179) NCT00794248	Organon and Co	Phase 4
Completed	New Nasal Applicator / New Formulation - User Study NCT00641979	AstraZeneca	Phase 2
Completed	Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With NCT00867191	Organon and Co	Phase 4
Completed	Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240) NCT00963469	Organon and Co	Phase 3
Completed	DNA Vaccine for Ragweed Allergic Adults NCT00346086	Johns Hopkins University	Phase 2
Completed	Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235) NCT00972738	Organon and Co	Phase 3
Completed	A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED) NCT00968149	Organon and Co	Phase 3
Completed	A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMP NCT00960141	Organon and Co	Phase 3
Completed	Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED) NCT00979901	Organon and Co	Phase 3
Completed	Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117) NCT00963599	Organon and Co	Phase 3
Completed	Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal A NCT03855189	Organon and Co	Phase 3
Completed	A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of NCT00987233	Apotex Inc.	Phase 3
Completed	Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE NCT00755066	Medical University of Vienna	N/A